Esperion Therapeutics Inc at JMP Securities Life Sciences Virtual Conference Transcript
Okay, great. Well, thanks to everybody for joining us for the JMP Securities Life Science Conference. My name is Roy Buchanan, I'm in the biotech research side on Jason Butler's team. And next company we have is Esperion Therapeutics. We rated it a Market Outperform. They are developing and commercializing its novel product for lipid management, bempedoic acid. And we're happy to have Sheldon Koenig with us today; he's President and CEO. He has been in the CEO seat -- I think it will be a month tomorrow after joining the Company as Chief Operating Officer at the end of last year.
So thanks for joining us for the fireside today, Sheldon. You've got a very deep experience in the lipid management space at multiple large companies. So maybe just briefly give us your background and talk about that experience.
Great, will do. Well, first of all, Roy, thank you so much. And on behalf of Esperion Therapeutics and myself, it's a pleasure to be here
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
